1de Gramont A, Vignoud J, Tournigand C, et al. Oxaliplatin with high dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer [J]. Eur J Concer,1997, 33(2): 214-219.
2Maindrnult G F, de Gramont A, Louvet C, et al. Evaluation of oxalipltin dose intensity in bimonthly leucovorin and 48 hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreat edmetastaticcolorectal cancet[J]. Oncology Multidisciplinary Resear
3Andre T, Bensmaine M A, Louvet C, et al. Multicenter, phase Ⅱ study of bimonthly high-dose leucovorin, fluorouracil infudion,and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen[J]. Clin Oncol, 1999,
4Sobrero A F, Aschele C, Bertino J R. Fluorouracil in colorectal cancer: A tale of two druga.Implications for biochemical modulation[J].J Clin Oncol, 1997, 15(1): 368-381.
5Machover D. Treatment of advanced colorectal and gastric adenocarinomas with 5-Fluorouracil and high-dose folinicacid [J]. Clin Onco1,1986,4(4):685.
6Raymond E, Faivre S, Woynarowski J M, et al. Oxaliplatin: mechanism of action and antineoplastic activity[J]. Semin Oncol, 1998, 25(2:Suppl 5):4-12.
